Pub Date : 2023-03-30DOI: 10.24875/imids.m22000028
Rebeca Pérez-Cabeza De Vaca, Deborah Campos-Martínez, María M. López-Chávez, Zu-lym Sánchez-Reyes, Raquel del C. Sánchez-Ramírez, Isidro A. Valdez-Bello, Carlos Paredes-Amenabar, T. Cortés-Espinosa
{"title":"El papel de las interleucinas en la enfermedad inflamatoria intestinal","authors":"Rebeca Pérez-Cabeza De Vaca, Deborah Campos-Martínez, María M. López-Chávez, Zu-lym Sánchez-Reyes, Raquel del C. Sánchez-Ramírez, Isidro A. Valdez-Bello, Carlos Paredes-Amenabar, T. Cortés-Espinosa","doi":"10.24875/imids.m22000028","DOIUrl":"https://doi.org/10.24875/imids.m22000028","url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127122331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-20DOI: 10.24875/imids.m22000026
Francisca Martínez-Silva
{"title":"Novedades en colitis ulcerosa: a propósito de la aprobación en México de un nuevo mecanismo de acción anti-interleucinas 12 y 23 (ustekinumab)","authors":"Francisca Martínez-Silva","doi":"10.24875/imids.m22000026","DOIUrl":"https://doi.org/10.24875/imids.m22000026","url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130177522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-20DOI: 10.24875/imids.m22000027
María M. López-Chávez, Zu-lym Sánchez-Reyes, Josué Mora-Pérez, T. Cortés-Espinosa, Rebeca Pérez-Cabeza De Vaca
{"title":"Conceptualización y regulación de los medicamentos biotecnológicos en México","authors":"María M. López-Chávez, Zu-lym Sánchez-Reyes, Josué Mora-Pérez, T. Cortés-Espinosa, Rebeca Pérez-Cabeza De Vaca","doi":"10.24875/imids.m22000027","DOIUrl":"https://doi.org/10.24875/imids.m22000027","url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114500863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-07DOI: 10.24875/imids.m22000025
E. Buganza-Torio, Christian Navarro-Gerrard
Primary biliary cholangitis is a chronic and progressive inflammatory autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts. It is considered a rare disease that predominates in women with a prevalence of 19 to 402 per million people. It is clinically characterized by fatigue, right upper quadrant pain, jaundice, pruritus, and biochemically with alkaline phosphatase (ALP) elevation at least > 1.5 times normal upper limit and the presence of mitochondrial antibody (AMA) positive at titers of 1:40 or more, liver biopsy is necessary in case of high suspicion and negative AMA or in case of suspected overlay syndrome (HAI/CBP). Early diagnosis and treatment of this disease can significantly improve the course of the disease by delaying liver cirrhosis and its complications and impacting patients’ quality of life.
{"title":"Colangitis biliar primaria","authors":"E. Buganza-Torio, Christian Navarro-Gerrard","doi":"10.24875/imids.m22000025","DOIUrl":"https://doi.org/10.24875/imids.m22000025","url":null,"abstract":"Primary biliary cholangitis is a chronic and progressive inflammatory autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts. It is considered a rare disease that predominates in women with a prevalence of 19 to 402 per million people. It is clinically characterized by fatigue, right upper quadrant pain, jaundice, pruritus, and biochemically with alkaline phosphatase (ALP) elevation at least > 1.5 times normal upper limit and the presence of mitochondrial antibody (AMA) positive at titers of 1:40 or more, liver biopsy is necessary in case of high suspicion and negative AMA or in case of suspected overlay syndrome (HAI/CBP). Early diagnosis and treatment of this disease can significantly improve the course of the disease by delaying liver cirrhosis and its complications and impacting patients’ quality of life.","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114096455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-07DOI: 10.24875/imids.m22000022
Jorge L. De León-Rendón, R. Y. López-Pérez
{"title":"Mesalazina: ¿cómo emplearla en la colitis ulcerosa crónica idiopática de leve a moderada?","authors":"Jorge L. De León-Rendón, R. Y. López-Pérez","doi":"10.24875/imids.m22000022","DOIUrl":"https://doi.org/10.24875/imids.m22000022","url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114847611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-07DOI: 10.24875/imids.m22000020
J. Aguilar-Hernández, Enoc Goudet-Vertiz, Liliam L. de la Cruz-Gapiz
{"title":"Breve historia de la terapia convencional en la colitis ulcerosa leve a moderada","authors":"J. Aguilar-Hernández, Enoc Goudet-Vertiz, Liliam L. de la Cruz-Gapiz","doi":"10.24875/imids.m22000020","DOIUrl":"https://doi.org/10.24875/imids.m22000020","url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116282592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-07DOI: 10.24875/imids.m22000021
J. López-Gómez, L. Rodríguez-Muñoz
{"title":"Mecanismo de acción de los aminosalicilatos","authors":"J. López-Gómez, L. Rodríguez-Muñoz","doi":"10.24875/imids.m22000021","DOIUrl":"https://doi.org/10.24875/imids.m22000021","url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124367973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-20DOI: 10.24875/imids.m22000018
E. Rendón-Huerta, J. L. Aceves, L. Montano
{"title":"Regulación de la función inmunitaria por células mesenquimales","authors":"E. Rendón-Huerta, J. L. Aceves, L. Montano","doi":"10.24875/imids.m22000018","DOIUrl":"https://doi.org/10.24875/imids.m22000018","url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122564109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：